IRIS
GAGLIARDINI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.409
NA - Nord America 976
AS - Asia 260
AF - Africa 22
SA - Sud America 17
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.691
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 968
GB - Regno Unito 291
IT - Italia 287
IE - Irlanda 228
DE - Germania 156
SE - Svezia 109
SG - Singapore 87
FR - Francia 83
RU - Federazione Russa 82
CN - Cina 68
VN - Vietnam 57
FI - Finlandia 54
UA - Ucraina 35
BE - Belgio 20
ES - Italia 19
NL - Olanda 16
BR - Brasile 15
AT - Austria 14
IN - India 10
CA - Canada 6
UG - Uganda 6
ET - Etiopia 5
ID - Indonesia 5
TR - Turchia 5
ZA - Sudafrica 5
AU - Australia 4
PT - Portogallo 4
HK - Hong Kong 3
JP - Giappone 3
AE - Emirati Arabi Uniti 2
EU - Europa 2
KR - Corea 2
LT - Lituania 2
MA - Marocco 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
TW - Taiwan 2
UZ - Uzbekistan 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TH - Thailandia 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 2.691
Salva come PNG Salva come JPEG
Città #
Southend 266
Dublin 216
Chandler 113
Santa Clara 109
Munich 104
Fairfield 96
Ashburn 84
Dong Ket 56
Ann Arbor 52
Helsinki 49
Siena 44
Woodbridge 40
Singapore 38
Princeton 33
Seattle 33
Jacksonville 31
Menlo Park 29
Milan 29
Wilmington 28
Houston 27
Beijing 21
Cambridge 21
New York 20
Málaga 19
Rome 19
Brussels 15
Lauterbourg 14
Dearborn 13
Shanghai 13
Düsseldorf 12
San Mateo 12
Frankfurt am Main 11
Vienna 11
Nanjing 10
Portsmouth 9
Boardman 8
Perugia 8
Florence 7
Nuremberg 7
Washington 7
Fremont 6
Moscow 6
Addis Ababa 5
London 5
Spring 5
Deiva Marina 4
Grosseto 4
Izmir 4
Jyväskylä 4
Kampala 4
Los Angeles 4
Naples 4
San Diego 4
San Francisco 4
Treviso 4
Bologna 3
Cagliari 3
Campobasso 3
Genoa 3
Guangzhou 3
Nanchang 3
Norwalk 3
Oxford 3
Porto 3
Recife 3
Redwood City 3
Scottville 3
Tokyo 3
Altavilla Milicia 2
Andover 2
Arezzo 2
Bandung 2
Bari 2
Brackenfell 2
Bronte 2
Bussero 2
Casciana Terme 2
Dallas 2
Elixhausen 2
Foggia 2
Ghent 2
Giarre 2
Hefei 2
Hillsboro 2
Hong Kong 2
Hyderabad 2
Jinan 2
Johannesburg 2
Leuven 2
Luino 2
Macerata 2
Manila 2
Newark 2
Ozieri 2
Palermo 2
Pescara 2
Phoenix 2
Pontirolo Nuovo 2
Pozzuoli 2
Rende 2
Totale 1.904
Salva come PNG Salva come JPEG
Nome #
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" 385
UTILIZZO DI MILTEFOSINA IN PAZIENTE CON LEISHMANIOSI MUCOSA ED INFEZIONE DA HIV 275
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 180
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 179
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 169
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 166
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 156
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort 145
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: a cohort study 144
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 132
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 116
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: A multi-cohort study 96
Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry 88
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 88
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 86
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: A retrospective study from the clinical practice 66
Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse 59
Efficacia viro-immunologica dei regimi antiretrovirali duplici e triplici contenenti dolutegravir: risultati di uno studio di coorte 58
Endocardite o non endocardite? Questo è il dilemma. 56
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 27
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort 23
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 20
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 19
Sexually transmitted infections in people with multidrug-resistant HIV 17
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors 17
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 12
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment‐experienced HIV‐positive patients: the experience of an Italian centre 7
Totale 2.786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.442
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 0 0 0 0 0 27 15 19
2020/2021385 17 20 3 21 57 29 33 41 37 36 13 78
2021/2022300 11 31 16 23 17 13 19 18 34 20 30 68
2022/2023421 26 51 65 41 25 76 15 32 33 28 15 14
2023/2024435 12 8 38 28 20 114 125 16 2 15 29 28
2024/2025766 19 31 81 33 148 107 108 83 123 33 0 0
Totale 2.786